ZEB2 and non-small cell lung carcinoma: Although several TFs have been generally associated with Teff cell differentiation [33], our metaVIPER-based analyses revealed that the transcription factor ZEB2 may be a key driver of the cytotoxic effector trajectory in NSCLC tumors.